- Home
- GXAI vs TNON Comparison
GXAI vs TNON Comparison
Compare GXAI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- TNON
- Stock Information
- Founded
- GXAI 2021
- TNON 2012
- Country
- GXAI United States
- TNON United States
- Employees
- GXAI N/A
- TNON N/A
- Industry
- GXAI
- TNON Medical Specialities
- Sector
- GXAI
- TNON Health Care
- Exchange
- GXAI Nasdaq
- TNON Nasdaq
- Market Cap
- GXAI 12.0M
- TNON 11.5M
- IPO Year
- GXAI 2023
- TNON 2022
- Fundamental
- Price
- GXAI $1.84
- TNON $1.17
- Analyst Decision
- GXAI
- TNON Strong Buy
- Analyst Count
- GXAI 0
- TNON 2
- Target Price
- GXAI N/A
- TNON $5.50
- AVG Volume (30 Days)
- GXAI 353.1K
- TNON 159.0K
- Earning Date
- GXAI 11-13-2025
- TNON 11-12-2025
- Dividend Yield
- GXAI N/A
- TNON N/A
- EPS Growth
- GXAI N/A
- TNON N/A
- EPS
- GXAI N/A
- TNON N/A
- Revenue
- GXAI $198,711.00
- TNON $2,947,000.00
- Revenue This Year
- GXAI N/A
- TNON $43.52
- Revenue Next Year
- GXAI N/A
- TNON $82.14
- P/E Ratio
- GXAI N/A
- TNON N/A
- Revenue Growth
- GXAI 72158.55
- TNON N/A
- 52 Week Low
- GXAI $1.00
- TNON $0.85
- 52 Week High
- GXAI $7.50
- TNON $5.85
- Technical
- Relative Strength Index (RSI)
- GXAI 55.95
- TNON 42.67
- Support Level
- GXAI $1.55
- TNON $1.16
- Resistance Level
- GXAI $2.00
- TNON $1.25
- Average True Range (ATR)
- GXAI 0.15
- TNON 0.05
- MACD
- GXAI 0.00
- TNON 0.00
- Stochastic Oscillator
- GXAI 64.42
- TNON 4.35
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.